@OptionsHawk Found out about $TMDX from your market outlook where you said they should be a core med-tech holding as their OCS system gains a dominant market share
@OptionsHawk Joe, is there a place in your 2022 Market Outlook that talks about stocks benefiting from rising rates? I know you’ve mentioned $STT and $SCHW before.